Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

New Book Offers Happiness and Hope to People Suffering from the Pandemic


Picture of the cover of Ms. Lundy's new book

Cover of Ms. Lundy’s New Book

Yes, you can find happiness and hope even during a pandemic and author, Lisa A. Lundy has the resources to help consumers of all ages deal with depression, anxiety, sadness, fear, loneliness and other emotions on her blog (http://www.LisaALundy.com), in her over 120 YouTube videos, and in her new podcast series titled Love.Life. Ms. Lundy’s book, blog, podcasts and YouTube videos are therapy and researched based providing proven techniques to help people who are suffering get their lives turned around. Ms. Lundy’s new book, Love.Life.™ A Handbook for Being Well Loved, Happy and Healthy, ISBN #978-0-578-81790-3, is 462 pages of practical steps, habits, practices, attitudes and beliefs to help people get inspired and moving in a positive direction towards love, happiness and wellness.

Over 50 of her YouTube videos are targeted to young people from teens to late thirties with special topics that young people face and tips on how to get through it because she believes that by addressing the needs of young people that the suicide rate can be reduced. A sampling of the topics addressed in her young people’s YouTube videos include: I Don’t Have Anyone to Turn to; I’m Really Struggling; I’m Lonely a Lot; I’m Really Unhappy; I Don’t Like Myself; I Don’t Have Any Hopes or Dreams; My Feelings Get Hurt a Lot; I Feel Like a Failure; and Nobody Loves Me. Making friends is frequently an issue for people of all ages but particularly for young people and she has a section of her videos devoted to making friends and friendship because it’s hard to make friends. Dysfunctional family dynamics are another category of videos designed to help young people. With between 70 to 96% of American families falling into the dysfunctional family category, dysfunctional families are a source of heartache and wounds for people of all ages.

Some of the titles of her podcasts include: Be Well Loved; Emotions as a Superpower; Managing Depression and Anxiety; Feel Better with Self-Care and Self-Compassion; Using Emotional Pain to Your Advantage; Dealing with Overwhelm; Being Happy When Life is Hard, and How to Have More Energy. New podcasts are coming out every week on topics to help consumers be empowered and learn how to be happy and healthy when life is hard.

If you are looking for the perfect gift for someone who is suffering during the pandemic, her eBook or her paperback book might be just be what you are looking for to help someone you love. She is sponsoring a Year of Freedom Giveaway on her website, http://www.LisaALundy.com, where consumers can win copies of her new book as well as other prizes through July 2021.

Ms. Lundy is no stranger to hardship having overcome multiple serious traumas throughout her life including starting her life over with basically nothing at age 58 completely unrelated to the pandemic. What she is exceptionally good at is how to be happy and highly functional when life is extremely hard. She was the first Executive Director of the Integrative Medicine Consortium, a former sales representative for Xerox, Bausch & Lomb, and another pharmaceutical company, and the author of a gluten-free and allergy cookbook. She has a B.S. degree from Penn State University, is a Distinguished Toastmaster, and has over 60 Internationally credentialed continuing education credits in psychology, human behavior, communication, leadership, and related subjects. Of all of her roles in life, her favorite is being a mother to her three amazing children.

Share article on social media or email:

Elev8 Cannabis’s Founder Appointed to National Cannabis Industry Association Board of Directors


Elev8 Cannabis today announced Seun Adedeji, its founder and chief executive, has been appointed to the National Cannabis Industry Association (NCIA) Board of Directors effective January 27. Today’s announcement marks the first board appointment for Mr. Adedeji.

“We are very pleased to welcome Seun Adedeji to the NCIA Board,” said Aaron Smith, co-founder and CEO of NCIA. “Seun’s experience managing multi-state dispensaries along with his unique perspective and visionary leadership will be invaluable to NCIA as we continue representing the cannabis industry on Capitol Hill and beyond.”

Mr. Adedeji, 27, who is the youngest multi-state dispensary owner in the country and the youngest African American dispensary owner, entered the cannabis business at age 23. He envisioned creating a cannabis dispensary chain dedicated to welcoming cannabis consumers from every walk of life. He wanted to provide veterans and others seeking relief through medical cannabis in a welcoming retail atmosphere to buy cannabis products and learn about them from an informed and knowledgeable staff. Mr. Adedeji developed the Elev8 Cannabis brand based on these ideals and opened the dispensary in 2017, in Eugene. He would later relocate to a different Eugene dispensary, where it has since operated. After obtaining a real estate and cannabis license in Massachusetts, Mr. Adedeji opened a second Elev8 Cannabis dispensary in the city of Athol. He will open additional stores in nearby Williamstown and Orange in the state by spring 2021. Before founding Elev8 Cannabis, Mr. Adedeji worked in telecommunications management and sales. He also attended college briefly in Dallas, Texas.

“My appointment to NCIA’s Board is important on multiple levels, and I could not be prouder to join a dedicated board that shares the similar objectives as I do regarding the growth of the cannabis industry,” said Mr. Adedeji.

Share article on social media or email:

Germinator Mobile Sanitizing and Disinfecting Opens in Nashville, Tennessee


Photo of the owner of Germinator Nashville.

Germinator Nashville is owned and operated by Bob Figurelli. The franchise will offer high-quality sanitizing and disinfecting services to businesses and residents in the area.

Staying ahead of germs, bacteria and other microscopic organisms is key to a clean and hygienic environment. Germinator provides businesses and residents with an effective solution that is validated by its Scientific Board comprised of top medical professionals, said Figurelli.

Germinator Mobile Sanitizing and Disinfecting is proud to announce the latest addition to its rapidly growing roster of franchise locations. The company has opened its doors in Nashville, Tennessee and will offer high-quality, effective sanitizing and disinfecting services to businesses and residents in the area.

The franchise is owned and operated by Bob Figurelli. After working in pharmaceutical sales for over 20 years in New Jersey and Manhattan hospitals and doctor’s offices, Bob saw firsthand the importance of sanitizing and disinfecting, and the effects a clean environment has on employees and patients. His industry experience, coupled with the current pandemic, inspired him to open a Germinator franchise.

“Staying ahead of germs, bacteria and other microscopic organisms is key to a clean and hygienic environment,” said Figurelli. “Germinator provides businesses and residents with an effective solution that is validated by its Scientific Board comprised of top medical professionals. The company’s HOCl disinfecting solution doesn’t use harsh chemicals or fumes and is fragrance free. These are crucial components as we do our best to maintain clean environments amid the pandemic.”

Germinator’s patent-pending methodology is the most unique and cost-effective means of providing enhanced antimicrobial protection for businesses and residences. The company first tests surfaces for ATP using a luminometer to detect light that can come from cellular activity. This measurement immediately provides the level of clean on a surface.

The next step is the application of Germinator’s Genesis surface treatment. Genesis is a one-step cleaner and broad-spectrum sanitizer and disinfectant treatment that harnesses the power of hypochlorous acid (HOCl). Derived from naturally occurring minerals, Genesis not only eliminates odors at their source, but kills a wide range of bacteria including Staphylococcus aureus, MRSA, Salmonella enterica and Pseudomonas aeruginosa, and viruses including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists (AOAC) germicidal spray standards for Hospital Grade Disinfection and is on the EPA’s N List of products determined to meet the criteria for use against SARS-CoV-2, the virus that causes COVID-19. As a result, this treatment will eliminate bacteria and viruses that may reside in your environment without the use of harsh chemicals or fumes.

Following Genesis, Germinator applies its Shield, a water-based quaternary ammonium compound that imparts a durable bacteriostatic finish. It is EPA-registered as effective against the growth of mold, mildew, algae and odor-causing bacteria. This application creates an invisible barrier that combats deterioration and discoloration and promotes freshness for up to three months.

The Genesis and Shield products are applied by using an electrostatic sprayer, which is the most efficient and effective means of delivering the products to the intended application sites. After Germinator’s surface treatment and protectant services, the company retests ATP levels to ensure the surfaces have achieved the intended results.

Based in Atlanta, Germinator was founded by Jeff Gill in 2015 with the vision of providing an effective method of proper sanitizing and disinfecting for businesses and households. The company continues to rapidly expand across the country.

“We’re proud of our expansion into Nashville, and we’re looking forward to providing the community with the best in sanitizing and disinfecting,” said Gill. “Bob has spent many years working in the medical field, so he knows the importance of creating and sustaining hygienic environments—especially this day and age. We are confident in his abilities to lead the Germinator brand into this new market, and we wish him the best with the opening of his franchise.”

Upholding the highest standards of sanitizing and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. Germinator’s research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr. —who was an Assistant to the United States Surgeon General for five administrations; Dr. Harold Smith, who has extensive expertise in cell biology, molecular biology and biochemistry, along with decades of experience leading sponsored research on infectious diseases for the National Institutes of Health (NIH); Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board; and Chad S. Johnson, Esq., a Harvard-trained corporate, legislative, and regulatory attorney with significant experience in advising health and biotechnology companies.

“During these unprecedented times, the need to focus on sterilizing agents within our country’s airports, public spaces and offices in order to decrease the spread of viral pathogens such as coronavirus is essential,” states Dr. Moore. “I am extremely happy to be a part of the Germinator team and lend my expertise in public health and regulatory affairs to what I feel is an immense asset to the containment effort.”

With Germinator, society can now have greater peace of mind and the freedom to live or work in a sanitized and disinfected environment. Businesses and residents in Nashville can learn more by visiting https://www.germinatornashville.com/ or calling (615) 987-1494.

Share article on social media or email:

TGen Leverages phoenixNAP’s Hardware-as-a-Service Powered by Intel® to Empower COVID-19 Research


Empowering COVID-19 Research with Cutting-Edge Tech

Empowering COVID-19 Research with Cutting-Edge Tech

“We got a more streamlined, powerful infrastructure that will give us enough power and memory, while at the same time providing us with a great degree of flexibility as our research expands,” said Glen Otero, VP Scientific Computing, TGen.

phoenixNAP®, a global IT services provider offering security-focused cloud infrastructure, dedicated servers, colocation, and specialized Infrastructure-as-a-Service technology solutions, announced a case study detailing its collaboration with Intel® on building an IT platform for a COVID-19 project by Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

In an effort to help the global fight against COVID-19, TGen proposed the creation of a centralized platform for knowledge and information sharing between researchers from all over the world. The platform is intended to automatically pull data related to COVID-19 sequenced genomes from multiple sources and provide an aggregated dataset to enable comparative research. This would help identify previously uncharacterized elements in the SARS-CoV-2 genome and observe important correlation between them for the purpose of improving diagnostics, vaccine constructs, and treatments for COVID-19.

Considering the volume and complexity of biomedical data, the platform needed powerful hardware to ensure seamless processing, reliable storage, and global availability. phoenixNAP and Intel collaborated to provide a customized solution to support these needs. phoenixNAP’s hardware-as-a-service (HaaS) powered by Intel® Xeon® Dual Gold 6258R CPUs and Intel NVMe’s (P4610) with Intel VROC, Intel NICs, and Intel Optane™ persistent memory met the needs of the project. The ultrafast network experience is enabled through a customized implementation of Intel® Tofino™ Programmable Ethernet Switch Products, which Intel® has offered since the acquisition of Barefoot Networks in June 2019.

“We needed a robust computational environment for large data volumes and sophisticated analytical tools. We have maintained compute infrastructure with phoenixNAP for years, but we needed to expand and customize it to support this project. We got a more streamlined, powerful infrastructure that will give us enough power and memory, while at the same time providing us with a great degree of flexibility as our research expands. Intel Optane PMem emerged as a logical solution to support large data sets,” said Glen Otero, VP Scientific Computing, TGen.

“Healthcare is becoming more intelligent, distributed, and personalized. Intel technologies are helping to enable a new era of smart, connected, value-based patient care, remote medicine and monitoring, individually tailored treatment plans, and more-efficient clinical operations. Intel-enabled technologies help optimize workflow to lower research and development costs, improve operational efficiency, speed time to market, and improve patient health,” said Rachel Mushahwar, VP and GM, Intel US Sales, Enterprise, Government and Cloud Server Providers

“TGen is doing an amazing job every day and this project is one of the examples of how they are actively working to make life-changing results. We discussed their project and knew that Intel will be open to collaborating with us on building a proper platform for it. We are excited for having the opportunity to work with both Intel and TGen on something this relevant to the entire world,” said Ian McClarty, President of phoenixNAP.

TGen has so far identified several new features in the SARS-CoV-2 genome and continues to focus on making new contributions to the cause. Its project addresses a critical need of the global biomedical community and promises to enhance further research on COVID-19. It also demonstrates the potential of using innovative technology to make a difference in the lives of millions of people.

Download full case study here: https://phoenixnap.com/company/customer-experience/tgen

About phoenixNAP

phoenixNAP® is a global IT services provider with a focus on cyber security and compliance-readiness, whose progressive Infrastructure-as-a-Service solutions are delivered from strategic edge locations worldwide. Its cloud, dedicated servers, hardware leasing and colocation options are built to meet always evolving IT businesses requirements. Providing comprehensive disaster recovery solutions, a DDoS-protected global network, hybrid IT deployments with software and hardware-based security, phoenixNAP fully supports its clients’ business continuity planning. Offering scalable and resilient opex solutions with expert staff to assist, phoenixNAP supports growth and innovation in businesses of any size enabling their digital transformation.

phoenixNAP is a Premier Service Provider in the VMware® Cloud Provider Program and a Platinum Veeam® Cloud & Service Provider partner. phoenixNAP is also a PCI DSS Validated Service Provider and its flagship facility is SOC Type 1 and SOC Type 2 audited.

Share article on social media or email:

Billon launches a Verifiable Certificate platform on distributed ledger, a milestone for the rollout of coronavirus immunization certificates


Enterprise DLT creator Billon Group has achieved a milestone in supporting the need for privacy in COVID-19 vaccinations, with the launch of a new form of GDPR compliant distributed ledger technology. The platform immutably stores any type of verifiable immunity certificate in a distributed ledger (DLT) where only the parties involved are aware of a citizen’s status. This database capability allows businesses and agencies to tailor end-user journeys to meet their needs.

Immunization certificates are an anticipated milestone in accelerating the post-pandemic recovery. With the rollout of COVID-19 vaccines, they will accelerate gradually and safely getting the economy back to “normal.”

Billon CEO Wojtek Kostrzewa explains: “We expect many governments will use paper-based records of who is vaccinated. In today’s world, people need digital solutions to display proof of required vaccinations to enter restaurants, stores, public places and their workplace. Individuals need to be sure their data is stored in a way that it cannot be exploited. All can benefit from the privacy that comes from encrypted, private data secured by our blockchain platform.”

Integrating personal identity with immunization documents in a compliant and tamper-proof manner on an accessible digital platform is key to the success of implementing immunity certificates. The immunity certificate brings together biometric data (for confirmation of identity) and vaccination verification (for confirmation of immunity).

The complete solution has three main elements:

  • Multi-tenant platform powered by Billon’s DLT serving as a back-end for storing and securely sharing identity data and immunization document;
  • A credential generator for health organizations executing and verifying vaccination;
  • Digital front-end journeys, which allow citizens to use mobile devices to present their certificates using QR codes.

Billon’s immunity certificate solution addresses considerable practical, legal and technological challenges concerning data security and identity protection across large populations. As it is blockchain-based, it provides decentralised and immutable data storage – the ultimate level of reliable, tamper-proof security. Once a certificate is linked to an ID, it is immutably stored, so it cannot be modified by any participating party. This feature ensures an individual’s capacity to control and protect their data is not compromised while mitigating the individual’s and the public health risk.

Benefits

For public institutions: The platform certifies who has completed the immunization requirements. Immunity certificates linked to identity allow tamper-proof validation on a digital platform. This protects individual privacy as the network operator cannot see any data. Only the publishers and the individual control the rights to share information.

For businesses: The platform offers a promising solution to businesses during the transition period by ensuring safe and secure access and activity as an alternative to heavy restrictions for longer periods of time. Businesses can link the solution to their needs, such as “ready-to-work”, “safe-to-travel”, and “safe-to-enter” type of applications. Employers can also link the solution to security access systems, establishing a compliant, highly secure and efficient solution to solve for access control.

For individuals: The platform lets individuals use their phone or other digital device to instantly provide proof of vaccination. As it provides on-demand verification at entry points, workplaces and public indoor spaces are kept safe during the transition period.

Innovate UK’s Fast Start Competition previously gave Billon Group a £50,000 grant to build a distributed ledger platform to store COVID-19 related certificates to support workers’ safe return to the workplace. This pilot scope, now refined, progresses to a fully functioning prototype for sharing, storage and verification of a wide range of workplace training and medical test documents. Billon is partnering with The Gekko Group for design and development of the user interface and mobile application. The companies recently won a £326,000 grant to deliver a solution to the market by the end of Q1 2021. This brings the value of the project to over $400,000.

About Billon

Billon created a DLT protocol and system specifically for tokenizing and transacting national currency and processing sensitive data in compliance with regulations, thus unleashing the transformational capabilities of blockchain technologies in the regulated world. Billon’s underlying protocol was designed for high throughput levels and low cost of maintenance in a range of environments. The system supports clients developing their own enterprise-grade applications in areas of Accounts & Transactions, Trusted Documents, and Identity & Data Sharing.

Billon Group Ltd. was founded in the UK in 2015, following several years of R&D in Poland. Its unique DLT protocol has been supported by many R&D grants, including the EU Horizon 2020 program. Billon is licensed to issue electronic money by regulators in the UK and Poland.

Billon’s growing client list includes leading companies such as FIS, Raiffeisen Bank International and BIK (the Polish credit reporting agency). Billon has offices in London and Warsaw.

For more information, visit http://www.billongroup.com. Follow Billon Group on LinkedIn & Twitter & Facebook.

Share article on social media or email:



Gauss Partners with Truepill in Strategic Effort to Deliver At-Home COVID-19 Rapid Testing to Millions


Gauss, a leading developer of computer vision-aided diagnostics for healthcare, today announced its partnership with Truepill™, the digital health platform powering consumer health experiences through its API-connected infrastructure, to help facilitate the delivery of at-home COVID-19 rapid tests to customers’ doorsteps.

The partnership supports Gauss’s efforts to scale manufacturing and operations in advance of commercialization of its smartphone-powered at-home COVID-19 rapid antigen test, which has been submitted to the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA).

“We want to be as ready as possible to deliver at-home rapid testing upon authorization,” said Siddarth Satish, Gauss Founder and CEO. “Public health officials and regulators are increasingly recognizing the potential impact of widely available at-home rapid antigen testing for COVID-19. We are working to produce a million tests over the next month and to scale to thirty million tests in the following quarter. Truepill will help provide the process and logistics infrastructure that enables us to deliver tests via a frictionless online consumer experience.”

Gauss previously announced its partnership with Cellex, Inc. on an at-home rapid antigen test that pairs a lateral flow assay for SARS-CoV-2 Antigen with a computer vision-enabled smartphone app in order to read the test result, allowing users to test themselves unassisted at home for active COVID-19 infection and obtain results in minutes.

The partnership with Truepill will launch with an eCommerce platform enabling users to buy tests online from their homes and will leverage Truepill’s systems and logistics infrastructure to enable processing of customer orders, integration with telehealth services, and same-day shipment of orders for home delivery. The integration will also enable Gauss to seamlessly process and fulfill digital orders from enterprise customers, such as third-party telehealth platforms.

Once they receive a test, users follow step-by-step video instructions in a smartphone app to correctly collect a nasal swab sample and perform a rapid antigen test. After 15 minutes, the app prompts users to scan their rapid test with their smartphone and the scanned image is analyzed with Gauss’s computer vision and neural network algorithms to generate a final test result. The app informs the user if the test result is negative or positive for SARS-CoV-2 antigens within seconds. A clinical trial submitted by Gauss to FDA for Emergency Use Authorization reported a 94.4% sensitivity and 99.2% specificity compared to a high-sensitivity RT-PCR.

“At Truepill, we’re inspired by partners who solve big problems with innovative solutions,” said Sid Viswanathan, Co-Founder and President of Truepill. “Scale and speed are essential to combat this pandemic, and we’re thrilled to partner with Gauss to provide the infrastructure needed to deliver their rapid, at-home antigen tests to millions of consumers across the country. This new program exemplifies the power of technology in healthcare, epitomizing what’s possible when we work together to empower patients with accessible, affordable solutions.”

Learn more about the Gauss/Cellex at-home rapid antigen test at covid19.gauss.com.

Note that an Emergency Use Authorization is not an FDA approval or clearance of a product but allows commercialization of the product for the duration of the declared public health emergency.

About Gauss

Gauss is a leader in computer vision in healthcare. Founded in 2011, Gauss’s mission is to digitally augment clinicians with software that radically improves diagnostic accuracy and leads to improved patient safety and clinical outcomes. Gauss’s flagship product, Triton, leverages computer vision to detect surgical and obstetric hemorrhage in real time and notifies clinicians who can enact timely intervention and treatment. Available on the iPhone, Triton has been widely adopted by health systems in the United States and is a recipient of the Apple Design Award, which recognizes the best in design, innovation and technology on Apple platforms. For more information, visit http://www.gauss.com.

About Truepill

Truepill is a digital health platform that delivers diagnostics, telehealth and pharmacy infrastructure to power consumer health experiences. Founded in 2016 with a unique B2B model, the company’s expansive suite of customizable, direct-to-patient solutions includes nationwide prescription fulfillment and delivery, a US-based network of licensed telehealth providers, an at-home lab testing network, white label packaging, product design and more. With seven owned and operated pharmacies, Truepill accreditations include URAC accredited mail order pharmacy, URAC accredited specialty pharmacy, NABP, Digital Pharmacy Accreditation and LegitScript. Learn more at http://www.truepill.com.

Share article on social media or email:

vFairs unites with CNIB to deliver an accessible virtual event for the partially sighted and blind community.


Making our platform accessible to all has been a mission dear to our hearts and we appreciate the opportunity to work with a team as passionate as CNIB to make that happen.

vFairs has collaborated with Canadian National Institute of the Blind (CNIB) to deliver a virtual event platform for their annual conference, Connecting the Dots. The successful two-day virtual conference took place on October 7-8, 2020 in English and on October 17-18, 2020 in French. 

Connecting the Dots, hosted by CNIB on vFairs, is Canada’s largest educational and professional development experience focused on braille, technology and employment for people who are blind or partially sighted. The two-day conference provides opportunities for attendees to learn about current trends and innovations in the sight loss community via workshops and panel discussions; network with industry experts; experience the latest advancements in braille and assistive technologies; and meet a community of braille transcribers, technology experts, academics, and entrepreneurs from diverse organizations and institutions. It also aims to provide a platform for employers, hiring managers and HR professionals to learn more about creating an accessible and inclusive work environment and meet new potential job candidates.

vFairs worked with CNIB to ensure the virtual conference platform was accessible. Incorporating features such as reverse contrast, enlarged fonts, and chat/voice enablement, was crucial to empower CNIB’s audience to attend a virtual conference independently. The event’s voice description feature was of particular interest to the attendees as it provided a narration of each page, and even descriptions of each individual booth. 

The partnership between vFairs and CNIB, and success of the event, was based on more than the availability of accessibility features and could not have been accomplished without the solution-oriented mindset of the vFairs team. 

Wayne Henshell, Head of CNIB’s Come to Work Program, expressed his delight by saying “the vFairs teams’ willingness to adapt and learn made this partnership a reality”. Even Muhammad Younas the CEO of vFairs spoke about the enlightening experience by saying “making our platform accessible to all has been a mission dear to our hearts and we appreciate the opportunity to work with a team as passionate as CNIB to make that happen”. 

The collaboration between CNIB and vFairs opened doors for a crucial conversation around accessibility and broke all notions that previously obstructed progress. 

CNIB is looking forward to hosting hybrid events, with some in-person capacity mixed with virtual components, to allow for greater reach. The success of this virtual conference has paved the way for future collaborations between vFairs and CNIB, hosting accessible and inclusive virtual events together. 

About vFairs

vFairs strives to deliver top-class virtual events for all audiences, with an intuitive platform that recreates physical events through an immersive online experience. With a range of powerful features and dedicated support for users around the world, vFairs removes the hassle from organizing, exhibiting at, and attending events such as conferences, trade shows, and career fairs. Contact the vFairs team to learn more or request a demo to see a virtual event in action. 

About CNIB

Founded in 1918, CNIB is a non-profit organization driven to change what it is to be blind today. We deliver innovative programs and powerful advocacy that empower people impacted by blindness to live their dreams and tear down barriers to inclusion. Our work as a blind foundation is powered by a network of volunteers, donors, and partners from coast to coast to coast. To learn more, visit cnib.ca.

Share article on social media or email:

John Barras DDS Announces Scholarship for Persons Diagnosed with Autism


News Image

Houston dentist Dr. John Barras, and his dental practice, Dentistry by John Barras, DDS, are pleased to announce they will be offering a scholarship for those who have been diagnosed with Autism Spectrum Disorder (autism or ASD). This is an educational scholarship in the amount of $1,000, which will be used to offset a portion of the tuition cost for attendance at a college or trade school chosen by the winning applicant. This is the third such scholarship offered by Dr. Barras since 2017 for those diagnosed with ASD.

Autism is a condition that can affect both communication and other aspects of a person’s life. Those persons often face challenges, and those challenges may affect their educational activities. The goal of Dr. Barras, the other dentists at the practice, and the entire staff is that by presenting this scholarship opportunity, an individual with autism will be provided with additional impetus to continue his or her schooling, and to move forward and achieve their educational goals.

Eligibility for the scholarship is limited to United States citizens with Autism Spectrum Disorder (DSM-V), and who anticipate enrolling at a college (or junior college) or a trade or vocational school in the near future. Although applicants do not need to be attending or enrolled at a school when they submit their application, the scholarship must be utilized within a year of the award.

Anyone who is interested in either applying for the scholarship, learning more about it or about Dr. Barras’ scholarship program, should visit their website. The website provides specific instructions for applying for the scholarship, the time for submission of the application, eligibility requirements, our privacy policy, as well as the process of selecting the winner. All applications, in order to be considered, must be submitted to us on or before January 28, 2022. The winner will be selected and announced not later than February 11, 2022.

All inquiries should be addressed to us, preferably by email, as follows:

Dentistry by John Barras, DDS

1330 Post Oak Blvd. #1300

Houston, TX 77056

(713) 993-9814

scholarshipcontests@gmail.com

Share article on social media or email:

CrossTx & HealthTechS3 Expand the Number of Community Hospitals Joining the Medicare Chronic Care Management Program


CrossTx, a leading cloud-based healthcare physician and health provider network technology platform supporting care coordination, patient referral orchestration and flexible digital health delivery models from telehealth to remote patient monitoring celebrates the ongoing successful collaboration with the award-winning healthcare consultancy and managed hospital firm, HealthTechS3. This partnership embraces best-of-breed medical care coordination technology with value-added Medicare-focused advisory services, leading to a valuable offering for hospitals and health centers.

This partnership helps deliver a compelling Chronic Care Management (CCM) solution to hospitals and health centers caring for Medicare beneficiaries in response to changes made back in 2015. The Centers for Medicare & Medicaid Services (CMS) had long identified Chronic Care Management (CCM) as an important factor associated with primary care contributing to better health care for Medicare beneficiaries. By 2015, CMS commenced paying separately under the Medicare Physician Fee Schedule (PFS) for CCM services delivered to patients struggling with multiple chronic conditions. From that point on CMS offered guidelines describing a new class of payable CCM service codes as well as identifying eligible practitioners, patients and the appropriate PFS billing requirements. Thereafter, CrossTx and HealthTechS3 jointly developed a compelling, economical and streamlined CCM compliant solution, involving the CrossTx network technology-powered care coordination capabilities along with the consultancy’s deep bench of Medicare reimbursement compliance and health provider subject matter expertise.

The combination of CrossTx’s superior platform technology fused with the award winning healthcare consulting and hospital management consulting services drives an incredibly successful partnership delivering hospitals and health centers across the United States a compelling Medicare-complaint CCM solution leading to not only reduced admission rates but also lower mortality and less health care expenditures. CrossTx CEO and Founder Chad Nybo recently declared “We are incredibly proud of this partnership, which has directly led to implemented CCM solutions in at least 70 community hospitals and health centers around the nation.” Nybo, who formerly managed product development for RightNow Technologies (acquired by Oracle), founded privately-held and profitable CrossTx nearly a decade ago to solve considerable technical challenges associated with health provider network efficiencies. He continued, “the key to this successful partnership is the highly complementary nature of the two firms: CrossTx provider health network enabling extensible care coordination along with deep Medicare regulatory and health practice expertise, offering clients a truly one-stop solution.”

Further, the results keep coming as the partnership not only ensures greater reimbursement for community hospitals but, more importantly, also contributes to higher quality health outcomes. At present approximately 3 million unique beneficiaries totaling 9% of the Medicare fee-for-service population receive care coordination services annually, with greater use of relevant services including CCM as well as Transitional Care Management (TCM) and advance care planning services. The turnkey CrossTx and HealthTechS3 partnership continuously expands the Medicare offering to contribute to the expansion of Medicare beneficiaries managed under CCM and related programs.

About CrossTx

Founded in 2010 in Bozeman, Montana, CrossTx has emerged as a premier cloud-based healthcare network platform company enabling mission-critical healthcare solutions driving improved patient outcomes while enabling health systems, hospitals, public health systems, value-based care organizations to telehealth-based delivery organizations the ability to improve care while achieving greater efficiency and revenue capture. CrossTx works with healthcare delivery organizations to optimize provider and patient networks via a suite of platform-based configured solutions including patient referral orchestration and discharge management, Medicare-based Chronic Care Management, care coordination, closed loop referral management and productivity, administration and compliance solutions for telehealth and remote patient monitoring applications. CrossTx serves healthcare-based clients across the United States. See the CrossTx website for more information at http://www.crosstx.com.

About HealthTechS3

Headquartered in Brentwood, Tennessee, the award-winning healthcare consulting and hospital management firm serves clients across the United States. The firm’s deep bench of senior health executives and subject matter experts offer consulting, managed services, and technology to support community hospitals of all sizes. We are dedicated to the goal of improving performance, achieving compliance, reducing costs and ultimately improving patient care. For more information see the HealthTechS3 website at http://www.HealthTechS3.com.

Media Contacts:

Jennifer LeMieux

Chief Operating Officer, HTS3

M: 615.429.6310

Jennifer.LeMieux@HealthTechS3.com

Daniel O’Connor

Chief Business Officer, CrossTx

M: 925-570-7486

daniel@crosstx.com

Share article on social media or email: